22/10/2023 ET Dupixent (dupilumab) - (LIBERTY-CUPID) $再生元制药(REGN)$ $831.63 ,SNY $53.13 PDUFA action date of October 22, 2023. 网页链接
26/10/2023 ET Vamorolone - (VISION-DMD) $催化剂制药(CPRX)$ $13.92 ,$Edgewise(EWTX)$ $6.45 PDUFA date of October 26, 2023. Catalyst entered into a definitive agreement with Santhera Pharmaceuticals under which Catalyst will enter into an exclusive North America license, manufacturing and supply the drug, noted June 20, 2023. 网页链接